Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis

Attila Hamar, Zoltán Szekanecz, A. Pusztai, Monika Czókolyová, É. Végh, Zoltán Pethő, Nóra Bodnár, Katalin Gulyás, Anita J. Horvath, Boglárka Soós,

Osteoporosis International · 2021 · 39 citations · 23 references

DOIFull text

Open access

Abstract

One-year tofacitinib treatment stabilized BMD in RA patients and resulted in a positive balance of bone turnover as indicated by bone biomarkers. Further studies are needed to evaluate the potential beneficial effects of JAK inhibitors on inflammatory bone loss.

References

23